CARDIOLOGY IMAGING Flashcards

1
Q

What are the advantages of Myocardial Perfusion studies?

A

A: Myocardial Perfusion studies are non-invasive, safe, and cheaper than an angiogram.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Q: What two main types of information does a Myocardial Perfusion study provide?

A

A: It provides information on 1) Myocardial perfusion and 2) the function of the left ventricle (LV).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Q: What are the two parts of a Myocardial Perfusion study?

A

A: The study consists of 1) the Myocardial Perfusion part and 2) the Ventriculogram part.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Q: Which medications can influence heart rate in a Myocardial Perfusion study?

A

A: β-blockers and ACE inhibitors (Angiotensin-Converting Enzyme Inhibitors) can influence heart rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to the calculation of Left Ventricular Ejection Fraction (LVEF) in the presence of atrial fibrillation (AF) or dysrhythmia?

A

A: The LVEF calculation becomes inaccurate because data collection uses an ECG with the R-wave as a trigger, which AF or dysrhythmia disrupts. However, visual evaluation can still provide information.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Q: Does atrial fibrillation (AF) or dysrhythmia affect the perfusion part of a Myocardial Perfusion study?

A

A: No, AF or dysrhythmia does not affect the perfusion part; it only influences the LVEF calculation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What radionuclide and carrier are used in Myocardial Perfusion studies?

A

A: Technetium (99mTc) is used as the radionuclide, and Isonitrile compound (sestaMIBI) acts as the carrier, specifically 99mTc-sestaMIBI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Q: What two factors determine the uptake of radionuclide into myocardial cells in Myocardial Perfusion studies?

A

A: Blood flow and the viability (metabolism) of myocardial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is attenuation in Myocardial Perfusion studies?

A

A: Attenuation is the interference of overlying soft tissue or nearby organs that may cause false positive or negative defects, commonly affecting the inferior wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Q: Which organs commonly cause attenuation defects in Myocardial Perfusion studies?

A

A: The breast (in females and obese males), diaphragm (mainly in men), gastrointestinal tract (GIT), and liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Q: How can attenuation defects be corrected in Myocardial Perfusion studies?

A

A: - Patient: Drinking two glasses of water or eating a “fatty meal”

Radiographer: Binding the breast
Equipment: Using CT attenuation correction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Q: What is the purpose of CT in Myocardial Perfusion studies?

A

A: CT is used for attenuation correction rather than anatomical imaging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the indications for Myocardial Perfusion studies?
.

A

A: - Redistribution indicates ischemia

Fixed defect indicates a previous myocardial infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Q: Why is only the left ventricle (LV) imaged in Myocardial Perfusion studies?

A

A: Because of the thickness of the left ventricular muscle wall. If the right ventricle is visible, it may indicate right ventricular hypertrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Q: What does a “cold” area on stress images in Myocardial Perfusion studies indicate?

A

A: A cold area (decreased radionuclide uptake) indicates a perfusion defect. If it fills in during the “at rest” study, it shows redistribution (ischemia). If it remains the same, it indicates a fixed defect (previous myocardial infarction).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Q: What is evaluated in the ventriculogram part of a Myocardial Perfusion study?

A

A: The ventriculogram part evaluates heart muscle movement dynamically to calculate left ventricular ejection fraction (LVEF) by assessing volumes during end-diastole and end-systole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Q: What is the purpose of visually evaluating the ventriculogram images in Myocardial Perfusion studies?

A

A: Visual evaluation helps confirm the findings from the perfusion images.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are relative contraindications for the perfusion and ventriculogram parts of a Myocardial Perfusion study?
A:

A

Perfusion part: β-blocker and ACE inhibitors (ACEI)
Ventriculogram part: Atrial fibrillation (AF) or dysrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Q: How long does a patient lie with their hands above their head during the perfusion part of a Myocardial Perfusion study, and why?

A

A: The patient lies with their hands above their head for about 20 minutes to prevent attenuation, which is corrected with CT attenuation correction.

20
Q

Q: How is the Left Ventricular Ejection Fraction (LVEF) calculated in the ventriculogram part of a Myocardial Perfusion study?

A

A: The computer calculates LVEF using heart wall movement to determine end-diastolic and end-systolic volumes, provided there is no AF.

21
Q

Q: What is the normal flow of blood and radioactivity through the central circulation?

A

A: Superior vena cava (SVC) → Right atrium (RA) → Right ventricle (RV) → Pulmonary artery → Lungs → Left atrium (LA) → Left ventricle (LV) → Aorta → Systemic circulation.

22
Q

Q: What are examples of central shunts that can affect blood and radioactivity flow in the heart?

A

Patent Ductus Arteriosus (PDA)
Atrial Septal Defect (ASD)
Ventricular Septal Defect (VSD)

23
Q

Q: How does a Ventricular Septal Defect (VSD) affect the flow of radioactivity in the heart?

A

A: Radioactivity flows normally through the central circulation, but part recirculates back to the RV and pulmonary artery instead of fully moving into systemic circulation.
part of the radio-activity to system

24
Q

Q: How does an Atrial Septal Defect (ASD) affect the flow of radioactivity in the heart?

A

A: With an ASD, radioactivity flows normally from the SVC to the RA, RV, and lungs, then to the LA. However, part of the radioactivity flows to the LV, while another part recirculates back to the RA, RV, and pulmonary arteries.

25
Q

Q: How does a Patent Ductus Arteriosus (PDA) affect the flow of radioactivity in the heart?

A

A: In PDA, radioactivity flows from the SVC to the RA, RV, and lungs, then to the LA and LV. Part of the radioactivity flows to the systemic circulation via the aorta, while another part recirculates back to the pulmonary artery and lungs.

26
Q

Q: What are the main indications for a Heart Blood Flow Study?

A

Quantifying central shunts (previously used to diagnose shunts)
Determining Right Ventricular Ejection Fraction (RVEF), approximately 52%
Evaluating gross central anatomy abnormalities (e.g., aortic aneurysm, dextrocardia, dextro-rotation).

27
Q

What does a Qp
ratio greater than 1.2 in a Heart Blood Flow Study suggest? (quantifying central shunts)

A

A: A Qp
ratio >1.2 could indicate the presence of a shunt.

28
Q

Q: Why is pulmonary hypertension (PHT) a relative contraindication in a Heart Blood Flow Study?

A

A: PHT causes decreased clearance, which makes analysis inaccurate and affects the reliability of the study.

29
Q

What radionuclide is used in a Heart Blood Flow Study, and does it have a carrier?

A

A: Technetium-99m pertechnetate (99mTcO4-) is used, and it does not require a carrier.

30
Q

Q: In a Heart Blood Flow Study, where is the initial inflow of radioactivity seen?

A

A: The initial inflow of radioactivity is seen in the superior vena cava (SVC) and right atrium (RA).

31
Q

Q: What areas are visible after radioactivity enters the RA in a Heart Blood Flow Study?

A

A: The right ventricle (RV), pulmonary truncus, and pulmonary arteries become visible.

32
Q

Q: In a Heart Blood Flow Study, what can be seen when radioactivity reaches the lungs?

A

A: The lungs become visible, while the left ventricle (LV) appears as a central photon-deficient area due to lack of radioactivity.

33
Q

Q: What happens to radioactivity in the lungs as it starts to clear in a Heart Blood Flow Study?

A

A: Radioactivity begins to clear from the periphery of the lungs, and the left side of the heart becomes visible.

34
Q

Q: What is observed in the left side of the heart as the Heart Blood Flow Study progresses?

A

A: There is further clearance from the lungs, with most radioactivity accumulating in the left side of the heart.

35
Q

Q: What signifies the near end of a Heart Blood Flow Study?

A

A: Almost complete clearance of radioactivity from the lungs, with radioactivity moving through the left side of the heart and entering the systemic circulation via the aorta.

36
Q

Q: What is the final observation in a Heart Blood Flow Study?

A

A: Only background radioactivity is visible, indicating complete clearance of radioactivity from the lungs.

37
Q

: What radioisotope is used in a Gated Blood Pool Study?

A

:
A: Tc-99m pertechnetate (99mTcO4-).

38
Q

: What is the carrier for radioactivity in a Gated Blood Pool Study?

A

A: The patient’s own labeled red blood cells (in vivo labeled RBCs with pirofosfaat).

39
Q

: What is the main indication for performing a Gated Blood Pool Study?

A

:
A: To measure the Left Ventricular Ejection Fraction (LVEF).

40
Q

How is data acquisition triggered in a Gated Blood Pool Study?

A

A: The R-wave of the ECG is used to trigger data acquisition, with the ECG connected to the camera.

41
Q

Q: How does atrial fibrillation (AF) affect a Gated Blood Pool Study?

A

A: AF influences the study by potentially affecting the accuracy of LVEF calculations, as it disrupts consistent data acquisition.

42
Q

: What type of heart information is gathered from a Gated Blood Pool Study?

A

A: Information on LV function, wall movement, diastolic function, LV and RV size, RV hypertrophy, and pericardial effusion.

43
Q

Q: What does a decrease in LVEF indicate in a Gated Blood Pool Study?

A

A: A decrease in LVEF, with increased end-diastolic ventricular volume (EDVV), typically indicates congestive dilated cardiomyopathy (CMP).

LV is dilated, weak contracting

44
Q

: What visual and computer-confirmed data is crucial in a Gated Blood Pool Study?

A

A: Blood volumes and changes in volume during the heart cycle are used to visually and computationally confirm LVEF.

45
Q

: Why might a Gated Blood Pool Study be less accurate in confirming RV function?

A

:
A: Due to less sensitivity in detecting conditions like Cor Pulmonale, compared to other imaging methods.

46
Q

contraindication of gated blood pool study

A

AF/dysrithmia

47
Q
A